Biziuleviciene G - Search Results

1

Anti-inflammatory potential of melanocortin receptor-directed drugs.

Skottner A, Post C, Ocklind A, Seifert E, Liutkevicius E, Meskys R, Pilinkiene A, Biziuleviciene G, Lundstedt T. Skottner A, et al. Among authors: biziuleviciene g. Ann N Y Acad Sci. 2003 Jun;994:84-9. doi: 10.1111/j.1749-6632.2003.tb03165.x. Ann N Y Acad Sci. 2003. PMID: 12851301

2

Quantitative evaluation of macrophage phagocytosing capacity by a fluorometric assay.

Miliukiene V, Biziuleviciene G, Pilinkiene A. Miliukiene V, et al. Among authors: biziuleviciene g. Acta Biol Hung. 2003;54(3-4):347-55. doi: 10.1556/ABiol.54.2003.3-4.12. Acta Biol Hung. 2003. PMID: 14711038

3

Oral tryptic casein hydrolysate enhances phagocytosis by mouse peritoneal and blood phagocytic cells but fails to prevent induced inflammation.

Kazlauskaite J, Biziulevicius GA, Zukaite V, Biziuleviciene G, Miliukiene V, Siaurys A. Kazlauskaite J, et al. Among authors: biziuleviciene g. Int Immunopharmacol. 2005 Dec;5(13-14):1936-44. doi: 10.1016/j.intimp.2005.06.015. Epub 2005 Jul 5. Int Immunopharmacol. 2005. PMID: 16275628

4

Quantitative evaluation of the transplanted lin(-) hematopoietic cell migration kinetics.

Kašėta V, Vaitkuvienė A, Liubavičiūtė A, Maciulevičienė R, Stirkė A, Biziulevičienė G. Kašėta V, et al. Among authors: biziuleviciene g. Transpl Immunol. 2016 Feb;34:54-9. doi: 10.1016/j.trim.2015.11.003. Epub 2015 Nov 18. Transpl Immunol. 2016. PMID: 26598388

5

Non-specific immunity-enhancing effects of tryptic casein hydrolysate versus Fermosorb for treatment/prophylaxis of newborn calf colibacillosis.

Biziulevicius GA, Zukaite V, Normantiene T, Biziuleviciene G, Arestov IG. Biziulevicius GA, et al. Among authors: biziuleviciene g. FEMS Immunol Med Microbiol. 2003 Nov 28;39(2):155-61. doi: 10.1016/S0928-8244(03)00222-0. FEMS Immunol Med Microbiol. 2003. PMID: 14625099 Free article. Clinical Trial.

6

An anti-inflammatory effect of murine fetal liver cells in BALB/c mouse contact hypersensitivity model.

Biziuleviciene G, Puidokaite G, Siaurys A, Mauricas M. Biziuleviciene G, et al. Int Immunopharmacol. 2007 Jun;7(6):744-9. doi: 10.1016/j.intimp.2007.01.012. Epub 2007 Feb 15. Int Immunopharmacol. 2007. PMID: 17466908

7

Lysozyme and similar lytic enzyme preparations should be considered antibiotics.

Biziulevicius GA, Biziuleviciene G, Kazlauskaite J. Biziulevicius GA, et al. Among authors: biziuleviciene g. Med Hypotheses. 2007;68(6):1420. doi: 10.1016/j.mehy.2006.11.016. Epub 2006 Dec 29. Med Hypotheses. 2007. PMID: 17196766 No abstract available.

8

A list of enzyme preparations covered by the term enzybiotics should not be restricted to bacteriophage-encoded peptidoglycan hydrolases (lysins).

Biziulevicius GA, Biziuleviciene G, Kazlauskaite J. Biziulevicius GA, et al. Among authors: biziuleviciene g. J Pharm Pharmacol. 2008 Apr;60(4):531-2. doi: 10.1211/jpp.60.4.0017. J Pharm Pharmacol. 2008. PMID: 18380927 No abstract available.

9

Human body as an operable reactor ('walking fermentator') for self-purposed production of immunostimulatory microbial lysis products.

Biziulevicius GA, Biziuleviciene G, Kazlauskaite J. Biziulevicius GA, et al. Among authors: biziuleviciene g. Med Hypotheses. 2008 Oct;71(4):600-1. doi: 10.1016/j.mehy.2008.06.003. Epub 2008 Jul 24. Med Hypotheses. 2008. PMID: 18656316 No abstract available.

10

Skin regeneration with bone marrow-derived cell populations.

Ramanauskaitė G, Kašėta V, Vaitkuvienė A, Biziulevičienė G. Ramanauskaitė G, et al. Among authors: biziuleviciene g. Int Immunopharmacol. 2010 Dec;10(12):1548-51. doi: 10.1016/j.intimp.2010.09.003. Epub 2010 Sep 22. Int Immunopharmacol. 2010. PMID: 20868755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters